Drug Insights

Making the Most Out of Synapse: Searching for Baclofen

7 February 2024
2 min read

Baclofen, sold under the brand name Lioresal among others, is a medication used to treat muscle spasticity such as from a spinal cord injury or multiple sclerosis. It may also be used for hiccups and muscle spasms near the end of life. It is taken by mouth or by delivery into the spinal canal. Common side effects include sleepiness, weakness, and dizziness. Serious side effects may occur if baclofen is rapidly stopped including seizures and rhabdomyolysis. Use in pregnancy is of unclear safety while use during breastfeeding is probably safe. It is believed to work by decreasing levels of certain neurotransmitters. Baclofen was approved for medical use in the United States in 1977. It is available as a generic medication. Click on the image below to begin the exploration journey of Baclofen through the Synapse database!

图形用户界面, 文本, 应用程序, 电子邮件

描述已自动生成

You can search for the latest pharmaceutical information such as drugs, targets, patents, transactions, clinical results, etc. through the Synapse database. Come and experience it!

图形用户界面, 文本, 应用程序, 聊天或短信

描述已自动生成

EU Commission clears GSK's drug Omjjara (momelotinib) for use
Latest Hotspot
4 min read
EU Commission clears GSK's drug Omjjara (momelotinib) for use
6 February 2024
GSK plc announced the European Commission's approval of Omjjara (momelotinib) for market launch. This daily oral drug inhibits both JAK1/JAK2 and activin A receptor type 1.
Read →
Synapse Simplified: How to Find Ciprofloxacin Information
Drug Insights
2 min read
Synapse Simplified: How to Find Ciprofloxacin Information
6 February 2024
Ciprofloxacin is a fluoroquinolone antibiotic used to treat a number of bacterial infections. It can be taken by mouth, as eye drops, as ear drops, or intravenously.
Read →
Alvotech Reveals Promising Preliminary Results for Potential Prolia® and Xgeva® Equivalent, AVT03
Latest Hotspot
2 min read
Alvotech Reveals Promising Preliminary Results for Potential Prolia® and Xgeva® Equivalent, AVT03
6 February 2024
Alvotech Reveals Encouraging Preliminary Findings from Drug Behavior Analysis of AVT03, a Potential Equivalent to Prolia® and Xgeva®.
Read →
A Complete Guide to Searching Diphenhydramine on Synapse
Drug Insights
2 min read
A Complete Guide to Searching Diphenhydramine on Synapse
6 February 2024
Diphenhydramine (DPH) is an antihistamine and sedative mainly used to treat allergies, insomnia, and symptoms of the common cold.
Read →
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.